Accessibility: Skip TopNav
BioCryst Announces U.S. Availability of ORLADEYO™ (berotralstat) for the Treatment of Hereditary Angioedema
ORLADEYO™ (berotralstat) capsules 150 mg
Format
JPEG
Source
BioCryst Pharmaceuticals, Inc.
Downloads
Original
Large
Medium
Small